Log in

iShares Nasdaq Biotechnology ETF News Headlines (NASDAQ:IBB)

$102.27
-0.76 (-0.74 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$101.49
Now: $102.27
$103.44
50-Day Range
$97.01
MA: $101.83
$105.55
52-Week Range
$89.01
Now: $102.27
$116.25
Volume1.76 million shs
Average Volume2.41 million shs
Market Capitalization$6.65 billion
P/E RatioN/A
Dividend Yield0.15%
Beta1.36

Headlines

iShares Nasdaq Biotechnology ETF (NASDAQ IBB) News Headlines

Source:
DateHeadline
Hepion Pharmaceuticals stock soars premarket-leading volume after positive data on liver disease treatmentHepion Pharmaceuticals stock soars premarket-leading volume after positive data on liver disease treatment
finance.yahoo.com - October 17 at 1:13 PM
Achillion Pharmaceuticals' stock rockets after Alexion Pharmaceuticals $930 million buyout dealAchillion Pharmaceuticals' stock rockets after Alexion Pharmaceuticals $930 million buyout deal
finance.yahoo.com - October 16 at 8:10 AM
Mondays ETF Movers: IBB, XOPMonday's ETF Movers: IBB, XOP
www.nasdaq.com - October 14 at 3:28 PM
VC Money Is Flowing Into BiotechsVC Money Is Flowing Into Biotechs
finance.yahoo.com - October 11 at 2:28 PM
3 Healthcare Stocks to Watch for the Long Run3 Healthcare Stocks to Watch for the Long Run
finance.yahoo.com - October 3 at 3:35 PM
iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Announces -- Dividend of $0.07iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Announces -- Dividend of $0.07
www.americanbankingnews.com - September 24 at 8:08 PM
Sell on the Pop Prospects: September 18 EditionSell on the Pop Prospects: September 18 Edition
finance.yahoo.com - September 18 at 3:10 PM
7 Biotech ETFs That Should Remain Healthy7 Biotech ETFs That Should Remain Healthy
investorplace.com - August 5 at 12:30 PM
Altimmune's stock soars after adding NASH candidate with purchase of Spitfire PharmaAltimmune's stock soars after adding NASH candidate with purchase of Spitfire Pharma
finance.yahoo.com - July 9 at 8:11 AM
Incyte enters license pact with Zai Lab to commercialize its cancer treatment in Greater ChinaIncyte enters license pact with Zai Lab to commercialize its cancer treatment in Greater China
finance.yahoo.com - July 2 at 8:12 AM
Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 millionAdaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million
finance.yahoo.com - June 18 at 6:43 AM
Kura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goalKura Oncology's stock soars toward record high after trial of lymphoma treatment achieves goal
finance.yahoo.com - June 14 at 8:22 AM
Cancer genomics company Personalis expects to raise up to $107 million in IPOCancer genomics company Personalis expects to raise up to $107 million in IPO
finance.yahoo.com - June 7 at 4:04 PM
Stoke Therapeutics to raise up to $107 million in IPOStoke Therapeutics to raise up to $107 million in IPO
finance.yahoo.com - June 7 at 8:20 AM
Foamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain NowFoamix (FOMX): A Beaten-Down Biotech Stock That Looks Like a Bargain Now
finance.yahoo.com - May 15 at 8:17 AM
The Best Biotech ETFs to Buy Ahead of ASCOThe Best Biotech ETFs to Buy Ahead of ASCO
247wallst.com - May 14 at 8:10 PM
Mustang Bio's stock soars to near 4-fold gain after deal to commercialize 'bubble boy' disease treatmentMustang Bio's stock soars to near 4-fold gain after deal to commercialize 'bubble boy' disease treatment
finance.yahoo.com - April 18 at 8:07 AM
A New Biotech ETF Gets ThematicA New Biotech ETF Gets Thematic
www.nasdaq.com - April 10 at 8:56 PM
Famous Five: These Biotech Stocks Notched Triple-digit Gains Famous Five: These Biotech Stocks Notched Triple-digit Gains
www.rttnews.com - April 10 at 8:52 AM
Concert Pharmaceuticals' stock takes a sharp dive after disappointing patent appeal board rulingConcert Pharmaceuticals' stock takes a sharp dive after disappointing patent appeal board ruling
finance.yahoo.com - April 9 at 8:16 AM
Advaxis' stock plummets after public offering prices at deep discountAdvaxis' stock plummets after public offering prices at deep discount
finance.yahoo.com - April 3 at 8:12 PM
Democrats, Republicans agree on legislation targeting drug pricesDemocrats, Republicans agree on legislation targeting drug prices
finance.yahoo.com - April 3 at 8:12 PM
Fridays ETF Movers: IBB, KREFriday's ETF Movers: IBB, KRE
www.nasdaq.com - March 29 at 7:49 PM
Alderya Therapeutics stock soars after conjunctivitis treatment trial meets key endpointsAlderya Therapeutics stock soars after conjunctivitis treatment trial meets key endpoints
finance.yahoo.com - March 26 at 8:10 AM
Curis' stock rockets on heavy volume after $135.7 million deal to sell portion of Erivedge royaltiesCuris' stock rockets on heavy volume after $135.7 million deal to sell portion of Erivedge royalties
finance.yahoo.com - March 25 at 7:48 PM
Biogen sets new $5 billion stock repurchase program in aftermath of stock plungeBiogen sets new $5 billion stock repurchase program in aftermath of stock plunge
finance.yahoo.com - March 25 at 8:28 AM
Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? - NasdaqShould You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? - Nasdaq
www.nasdaq.com - March 21 at 8:30 AM
Novocure Chief Science Officer Eilon Kirson to retire after 7 years in the roleNovocure Chief Science Officer Eilon Kirson to retire after 7 years in the role
finance.yahoo.com - March 21 at 8:30 AM
How to Choose an ETF - BarronsHow to Choose an ETF - Barron's
www.barrons.com - March 18 at 8:04 AM
PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agentPhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent
finance.yahoo.com - March 18 at 8:04 AM
Gilead Stock Could Surge to $84, Says AnalystGilead Stock Could Surge to $84, Says Analyst
finance.yahoo.com - March 14 at 7:30 PM
Akari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meetingAkari Therapeutics' stock rockets on massive volume after 'successful' pre-IND FDA meeting
finance.yahoo.com - March 13 at 7:17 PM
Is iShares Nasdaq Biotechnology Index Fund a Buy?Is iShares Nasdaq Biotechnology Index Fund a Buy?
finance.yahoo.com - March 11 at 7:53 PM
Biotech ETF Sees Record Volume After FDA Commissioner ResignsBiotech ETF Sees Record Volume After FDA Commissioner Resigns
www.bloomberg.com - March 8 at 8:10 AM
iShares Nasdaq Biotechnology (IBB) Shares Cross Below 200 DMAiShares Nasdaq Biotechnology (IBB) Shares Cross Below 200 DMA
www.nasdaq.com - March 7 at 8:20 AM
MId-Day ETF Update: ETFs, US Stocks Reverse into Negative Territory on Weak US Manufacturing Data - NasdaqMId-Day ETF Update: ETFs, US Stocks Reverse into Negative Territory on Weak US Manufacturing Data - Nasdaq
www.nasdaq.com - March 1 at 7:22 PM
Immunogen's stock loses nearly half its value after trial of cancer treatment fails to meet primary endpointImmunogen's stock loses nearly half its value after trial of cancer treatment fails to meet primary endpoint
finance.yahoo.com - March 1 at 8:11 AM
7 of the Best Biotech ETFs7 of the Best Biotech ETFs
investorplace.com - February 27 at 3:06 PM
Anchiano Therapeutics IPO prices below assumed price - MarketWatchAnchiano Therapeutics IPO prices below assumed price - MarketWatch
www.marketwatch.com - February 13 at 6:47 PM
Anchiano Therapeutics stock set to close well below its IPO price - MarketWatchAnchiano Therapeutics' stock set to close well below its IPO price - MarketWatch
www.marketwatch.com - February 13 at 6:47 PM
Anchiano Therapeutics' stock set to close well below its IPO priceAnchiano Therapeutics' stock set to close well below its IPO price
finance.yahoo.com - February 12 at 7:31 PM
Gossamer Bio trading 3% above initial IPO price - MarketWatchGossamer Bio trading 3% above initial IPO price - MarketWatch
www.marketwatch.com - February 9 at 8:07 AM
What Are Analysts Recommending for AbbVie after Q4 2018 Results?What Are Analysts Recommending for AbbVie after Q4 2018 Results?
finance.yahoo.com - January 28 at 6:31 PM
Rigel Pharmaceuticals stock up 9% after announcing licensing agreement with GrifolsRigel Pharmaceuticals stock up 9% after announcing licensing agreement with Grifols
finance.yahoo.com - January 23 at 8:04 AM
Will AVRO Reverse Course In Run-up To February Event? Will AVRO Reverse Course In Run-up To February Event?
www.rttnews.com - January 22 at 2:03 AM
Trade of the Day: The Biotechnology Stocks ETF Is Running Out of SteamTrade of the Day: The Biotechnology Stocks ETF Is Running Out of Steam
investorplace.com - January 17 at 7:15 AM
Biotech ETFs Rip Higher to Start 2019Biotech ETFs Rip Higher to Start 2019
finance.yahoo.com - January 14 at 6:16 PM
Biotechs breaking out, and heres why some market experts think an even bigger rally is aheadBiotech's breaking out, and here's why some market experts think an even bigger rally is ahead
finance.yahoo.com - January 8 at 8:10 AM
Two ways to play the biotech boomTwo ways to play the biotech boom
finance.yahoo.com - January 8 at 8:10 AM
Axonics Ready To Charge Up? Axonics Ready To Charge Up?
www.rttnews.com - January 7 at 12:52 AM
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel